0 Axial Therapeutics to Present at the 2020 RBC Capital Markets Healthcare Private Company ConferenceDec. 8, 2020 READ MORE
2 Results from Axial Therapeutics Phase1b/2a Study of AB-2004 in Adolescents with Autism Spectrum Disorder Met Primary Endpoint and Reduced Irritability and Other SymptomsResults to be Presented at The BRAIN Foundation Synchrony 2020 Conference Axial R&D Leader to Chair Day-long Session on Clinical Trials for ASD and New Therapeutics WALTHAM, Mass., Dec. 3, [...] READ MORE
